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A report by Seliger et al. on statin use and risk of glioma
prompted Greenland to write a letter-to-the-editor in which
he again explains why lack of statistical significance must
not be interpreted as lack of association [1, 2]. Greenland
and colleagues have also stressed recently that a statisti-
cally significant association very well may be due to
chance [3]. These two statements hold just the same
regardless of whether the statistical significance judgment
is based on if the P value is smaller than 5% or if the
confidence interval excludes the no-effect value.
The consequences of dividing results into the two sep-
arate categories statistically significant and non-significant
have been discussed extensively. The topic is part of the
curriculum in courses and it appears in textbooks. Journals
have had editorial comments and groups of experts with
various tasks have provided guidance. Individual scientists
have discussed this in commentaries like the current and in
more comprehensive formats and there are other letters to
the editor than Greenland’s that point to problematic use of
the significance concept. For an extensive list of references,
see a recent article in EJE [3].
Yet, the reporting style that points out whether associ-
ations are significant or not remains common. Although
there is at most a thin marginal difference between a lower
confidence bound of .99 and one of 1.01 we have all
noticed disappointed faces when results start to appear and
it becomes clear that figures don’t quite reach statistical
significance and we have noted correspondingly happy
faces in case of the opposite. A mechanism by which
chance could be put out of the equation and the researcher
freed to focus on systematic errors and biologic plausibility
for assessment of causality would have been a great gift to
the research community. But significance testing of null-
hypotheses was not designed to serve this purpose. It was
developed as a decision-making tool, and decisions are
rarely made from the outcome of one single study.
A meta-analysis that offers new insights into ways of
reporting study results is published in the current issue of
European Journal of Epidemiology [4]. It is an attempt to
estimate trends in usage of P values, significance tests, and
confidence intervals in close to 90,000 articles published in
five general medical journals and in seven epidemiology
journals. The basis is the computerized abstracts in
PubMed, which allows for the large study size but limits
the information to the wordings in the abstract. The key
findings are that confidence intervals presented in their own
right and not as proxies for statistical tests are becoming
more common, particularly in epidemiology journals.
Although significance testing is becoming less popular in
most epidemiology journals and some widely read medical
journals, it is still very common in some prominent medical
journals. While these results signal an improvement over
time and a rather positive trend, particularly among epi-
demiology journals, it is worth noting that still only about
40% of the articles in epidemiology journals rely solely on
confidence intervals for assessing precision in the reported
estimates, based on what shows up in the abstracts. In the
selected medical journals this figure was about 20%.
A few things are immediately clear. First, editorial
policy plays a role as evidenced by the position that Epi-
demiology takes. Confidence intervals have always been
the predominant mode of reporting in this journal as the
result of an editorial policy that was in place from the start
of the journal. Second, there is a clear difference between
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epidemiology journals and medical journals with consid-
erably more reliance on confidence intervals in the epi-
demiology journals; the data don’t allow a comparison
restricted to reports of epidemiological studies. Third, the
prevalence of statistical significance testing varies across
medical journals and in particular prevails over time in the
high impact journals JAMA, NEJM, and Lancet.
Thus, this meta-analysis informs about the prevalence
and trends in usage of significance testing, but we still
don’t know why this so often is the reporting style of
choice. We also don’t know the reason for the differences
in this respect between types of journal and between
individual journals. A list of candidates for explanation is
provided below. These explanations are based on a blend of
different factors including compliance with perceived or
real expectations from the surrounding research commu-
nity, on convenience on the side of the researcher when
reporting results, and on ignorance.
This is the list:
1. If the editor of the intended journal requests statements
as to whether or not results are statistically significant
these will most likely be provided.
2. Indeed, it may even suffice that the editor is anticipated
to request such statements for them to be provided.
3. Most researchers do not want to be seen as exaggerating
their own findings and that makes some researchers
particularly careful with associations that are non-
significant and they may therefore be anxious to declare
whether results pass the cut off or not.
4. A researcher may think that after all, a significant result
is stronger than one that isn’t and a non-significant
result weaker than one that is. Also when confidence
intervals are used as the mood of reporting the
researcher may therefore choose to emphasize if the
confidence interval includes the null or not (although
obvious to the reader anyway) by referring to the results
as significant or non-significant.
5. Describing the results of a study becomes easy with
statistical significance language because it provides
standardized phrases. Without this language the
researcher must describe the findings with own words.
6. Research typically results in more than one result, and
certain choices need to be made by the researcher when
the results are reported and discussed. Choosing the
ones to report or highlight is made easy if based on
statistical significance.
7. A somewhat similar situation may arise with meta-
analysis. The researcher who conducts the meta-analysis
may find it convenient to classify the selected studies into
whether their results are significant or not, regardless of
how they were presented in the original article. The meta-
analysis may then be based on a count of the positives
and the negatives. This may well result in that a set of
positive studies, but with confidence intervals including
the null, are considered as all negative, although taken
together they could be overwhelmingly positive.
8. It is conceivable that some statistical courses cover
various approaches to random variation in a neutral tone
and commenting that different methods to a certain
extent are interchangeable, but without a proper discus-
sion of relevance and interpretation. If such courses are
not accompanied by method-oriented epidemiology
training the researcher is left alone and in the lack of
guidance may decide to go for significance testing.
9. A researcher without formal training in epidemiology,
perhaps in a clinical setting, who conducts an epidemi-
ological study, may turn to a biostatistician for assis-
tance when analyzing the data. The biostatistician may
be indifferent as to the reporting style and prepared to
deliver whatever is requested. The two may together
decide to go for significance tests.
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